The company in question is, Opko Health, Inc. (NASDAQ:OPK) currently with a stock price of 9.51 (-0.51% today). The market cap for Opko Health, Inc. is 5537.73, and is in the sector Healthcare, and Biotechnology industry. The target price for Opko Health, Inc. is 15.25. Currently Opko Health, Inc. is trading with a P/E of 36.77, and a forward P/E of 281.18. Average volume for Opko Health, Inc. is 3091.42 and so far today it is 928418.
Performance in the last year for Opko Health, Inc. has been 5.64%. For EPS growth, Opko Health, Inc. has seen a growth of 84.90%, and is looking to grow in the next year to 160.00%. More long term stats show that EPS growth has been -0.50% over the last five years and could be 0.00% for the next five years. Opko Health, Inc. has seen sales growth quarter over quarter at 742.20%, with EPS growth quarter over quarter at 130.10%. The 20-day simple moving average is -5.09%, with the 200-day simple moving average coming to -2.74%.
Since the IPO date for Opko Health, Inc. on the 11/02/1995, Opko Health, Inc. has seen performance year to date to be -4.88%. With Opko Health, Inc. trading at 9.51, the dividend yield is *TBA, and the EPS is 0.26.
So could Opko Health, Inc., be undervalued? Well as said before P/E is 36.77. The PEG is *TBA, P/S is 5.19 and the P/B is at 2.6. The P/cash is 32.27, with P/free cash flow at *TBA.
Opko Health, Inc. ability to deal with debt shows that the current ratio is 1.8, and the quick ratio is 1.6. This is with long term debt/equity at 0.04, and total debt/equity at 0.04.
In terms of margins, Opko Health, Inc. has a gross margin of 52.10%, an operating margin of -1.40% and a profit margin of 12.50%.Payout ratio for Opko Health, Inc. is 0.00%. Return on assets come to 4.70% with return on investment coming to 0.70%.
Insider ownership for Opko Health, Inc., is at 1.60% and institutional ownership comes to 21.00%. Outstanding shares are at 579.26. While shares float is 330.06. The float short is currently 20.95%, and short ratio is 22.36.